We are live on !
Find out more
Longaeva Partners Portfolio holdings
AUM
$4.58B
Turnover
75.17%
1-Year Est. Return
43.91%
This Fund
S&P 500
This Quarter Est. Return
+20.82%
1 Year Est. Return
+43.91%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.58B
AUM Growth
+$1.88B
(+69%)
Cap. Flow
+$1.03B
Cap. Flow % of AUM
Cap. Flow %
22.6%
Top 10 Holdings %
Top 10 Hldgs %
29.9%
Holding
435
New
231
Increased
47
Reduced
58
Closed
96
Avg Time Held
Equity + Options
0.1
years
Top 10 Avg Time Held
Equity + Options
0
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$101M |
| 2 |
JPMorgan Chase
JPM
|
+$79.2M |
| 3 |
Moody's
MCO
|
+$58.8M |
| 4 |
Fifth Third Bancorp
FITB
|
+$58.5M |
| 5 |
LPL Financial
LPLA
|
+$56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PNC Financial Services
PNC
|
+$68M |
| 2 |
ACM Research
ACMR
|
+$48.8M |
| 3 |
Citizens Financial Group
CFG
|
+$47.1M |
| 4 |
Vishay Intertechnology
VSH
|
+$46.3M |
| 5 |
Goldman Sachs
GS
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.82% |
| 2 | Financials | 20.39% |
| 3 | Healthcare | 17.29% |
| 4 | Industrials | 14.57% |
| 5 | Technology | 7.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
TotalEnergies
TTE
$205B
| $6.22M | 0.14% |
+79,932
| New | +$7.07M |
2026 Q2
0 quarters
|
|
152
Tesla
TSLA
$1.47T
| $6.21M | 0.14% |
+14,761
| New | +$5.87M |
2026 Q2
0 quarters
|
|
153
Legend Biotech
LEGN
$3.75B
| $6.19M | 0.14% |
+214,355
| New | +$5.78M |
2026 Q2
0 quarters
|
|
154
Target
TGT
$69.4B
| $6.14M | 0.13% |
47,041
-200,459
| -81% | -$25.5M |
2026 Q1
1 quarter
|
|
155
Kyivstar Group
KYIV
$3.07B
| $6.04M | 0.13% |
373,624
-84,794
| -18% | -$1.11M |
2026 Q1
1 quarter
|
|
156
Lumexa Imaging Holdings
LMRI
$1.12B
| $5.96M | 0.13% |
528,801
-28,622
| -5% | -$261K |
2025 Q4
2 quarters
|
|
157
CALL
Oracle
ORCL
$382B
| $5.94M | 0.13% |
+40,500
| New | +$7.34M |
2026 Q2
0 quarters
|
|
158
RBC Bearings
RBC
$14.9B
| $5.71M | 0.12% |
8,871
-2,612
| -23% | -$1.55M |
2026 Q1
1 quarter
|
|
159
Oscar Health
OSCR
$9.6B
| $5.7M | 0.12% |
+200,000
| New | +$4.31M |
2026 Q2
0 quarters
|
|
160
SOLV Energy Inc
MWH
$4.33B
| $5.67M | 0.12% |
166,390
+143,073
| +614% | +$5.19M |
2026 Q1
1 quarter
|
|
161
QXO Inc
QXO
$10.9B
| $5.48M | 0.12% |
+316,977
| New | +$5.9M |
2026 Q2
0 quarters
|
|
162
Church & Dwight Co
CHD
$25B
| $5.45M | 0.12% |
+56,271
| New | +$5.38M |
2026 Q2
0 quarters
|
|
163
Helmerich & Payne
HP
$3.89B
| $5.4M | 0.12% |
+165,033
| New | +$6.18M |
2026 Q2
0 quarters
|
|
164
BWX Technologies
BWXT
$11.7B
| $5.36M | 0.12% |
27,562
+22,653
| +461% | +$4.72M |
2026 Q1
1 quarter
|
|
165
Agilon Health
AGL
$1.51B
| $5.33M | 0.12% |
+49,741
| New | +$3.26M |
2026 Q2
0 quarters
|
|
166
Abivax
ABVX
$7.68B
| $5.33M | 0.12% |
+40,000
| New | +$4.53M |
2026 Q2
0 quarters
|
|
167
Monte Rosa Therapeutics
GLUE
$925M
| $5.25M | 0.11% |
+216,792
| New | +$4.1M |
2026 Q2
0 quarters
|
|
168
Erasca
ERAS
$5.03B
| $5.25M | 0.11% |
286,322
+115,089
| +67% | +$1.65M |
2026 Q1
1 quarter
|
|
169
D.R. Horton
DHI
$41.3B
| $5.22M | 0.11% |
+32,049
| New | +$4.78M |
2026 Q2
0 quarters
|
|
170
Kratos Defense & Security Solutions
KTOS
$7.26B
| $5.19M | 0.11% |
+104,177
| New | +$6.3M |
2026 Q2
0 quarters
|
|
171
Monopar Therapeutics
MNPR
$474M
| $5.17M | 0.11% |
+55,834
| New | +$3.46M |
2026 Q2
0 quarters
|
|
172
BJs Wholesale Club
BJ
$13.4B
| $5.15M | 0.11% |
+59,000
| New | +$5.4M |
2026 Q2
0 quarters
|
|
173
Pentair
PNR
$8.83B
| $5.12M | 0.11% |
66,799
+16,388
| +33% | +$1.3M |
2026 Q1
1 quarter
|
|
174
NVIDIA
NVDA
$5.09T
| $5.03M | 0.11% |
25,155
-72,973
| -74% | -$15M |
2026 Q1
1 quarter
|
|
175
Halliburton
HAL
$28.9B
| $5.01M | 0.11% |
+147,493
| New | +$5.76M |
2026 Q2
0 quarters
|
|
Similar funds
BWA
Longaeva Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Longaeva Partners held 435 positions worth $4.58B, up 69% from $2.7B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Longaeva Partners deployed $1.03B of net new capital in Q2 2026, opening 231 new positions and adding to 47 existing holdings. Its largest new stake was SpaceX: 596,829 shares worth $102M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was ACM Research, an estimated $48.8M trimmed.
- Longaeva Partners's largest Q2 2026 buy was SpaceX: 596,829 shares worth $102M.
- Longaeva Partners added most to Mettler-Toledo International in Q2 2026, an estimated $39.4M increase.
- Longaeva Partners's biggest Q2 2026 reduction was ACM Research, cutting an estimated $48.8M.
- Longaeva Partners fully exited PNC Financial Services in Q2 2026, selling an estimated $68M.
- Longaeva Partners's ten largest holdings make up 30% of its $4.58B portfolio in Q2 2026.
- Longaeva Partners opened 231 new positions and closed 96 in Q2 2026.
- Longaeva Partners's portfolio value rose 69% quarter-over-quarter to $4.58B.
Based on Longaeva Partners's 13F filing for Q2 2026, filed 14 Aug 2026.